Previously reported beneficial effects of iNOS inhibition on emphysema and PH reversal in preclinical models of COPD are thus likely mediated by (an)other lung cell-type(s), such as fibroblasts or (other) pulmonary vascular cells. Here, NOS2 is linked to chronic obstructive pulmonary disease.